513 material Form 8-K filings that 427 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
RenaissanceRe Holdings said director Brian G. J. Gray retired from its board effective November 6, 2024, with no disagreement with the company. Loretta J. Mester, a former president of the Federal Reserve Bank of Cleveland, was appointed to fill the vacancy and was named to the Investment and Risk Management Committee. The change is a routine board transition that does not alter reported financial results.
Brian G. J. Gray retired from the board effective November 6, 2024, after serving since 2013
Loretta J. Mester appointed Class II director effective November 6, 2024, serving until the 2027 annual meeting
Mester receives a prorated 2024 cash retainer of $62,500 and restricted stock valued at $165,000, vesting in three annual installments from March 1, 2025
Brinker's board approved performance share awards under a new Fiscal 2025 Executive Performance Share Retention Plan for three executives, with target values of $20 million for CEO Kevin Hochman, $3 million for Aaron White and $2 million for George Felix. At the November 6, 2024 annual meeting, shareholders re-elected all ten director nominees and approved the auditor ratification, the executive compensation proposal and a new 2024 Stock Option & Incentive Plan.
Target awards: Kevin Hochman (CEO and President) $20,000,000; Aaron White (Chief People Officer) $3,000,000; George Felix (Chief Marketing Officer) $2,000,000
Awards pay out from 0% to 200% of target based on five-year total shareholder return from September 26, 2024 through September 25, 2029, relative to the S&P 1500 Hotels, Restaurants and Leisure Index; target requires the 60th percentile
Executives must remain employed through September 25, 2029 to earn any performance shares
Shareholders approved KPMG LLP as Independent Auditors for Fiscal 2025 (39,660,145 for, 856,718 against) and the 2024 Stock Option & Incentive Plan (36,637,438 for, 779,256 against)
The Andersons completed its purchase of a 65% ownership interest in Skyland Grain, LLC on November 1, 2024, for $85.0 million, funded with cash on hand and subject to customary working capital adjustments. Skyland's results will be consolidated into The Andersons' financial statements, and Skyland entered a $378 million credit agreement that is secured by its assets and non-recourse to The Andersons.
65% ownership interest in Skyland Grain, LLC purchased for $85.0 million, completed November 1, 2024
Skyland entered an amended and restated credit agreement with COBANK, ACB and Farm Credit Mid-America, PCA, including a three-year $300 million revolving credit facility and $78 million of term notes
$300 million revolver and $67 million of term notes bear variable rates based on SOFR plus a spread; $11 million of term notes bear fixed rates of 4.0% to 5.8%
Skyland has more than 7,000 active co-op members across more than 50 grain and agronomy locations
Archer-Daniels-Midland increased its board from 11 to 12 directors and elected David R. McAtee II, AT&T's senior executive vice president and general counsel, as an independent director effective immediately. The filing describes this as a board addition with no reported financial terms, and McAtee joins the Nominating and Corporate Governance and Compensation and Succession committees.
Board size increased from 11 to 12 directors on November 1, 2024, with McAtee elected to fill the new seat
McAtee has been AT&T's worldwide General Counsel since 2015 and will serve until the next annual meeting of stockholders
McAtee will sit on the Nominating and Corporate Governance and Compensation and Succession committees; his director pay follows the policies in the April 10, 2024 proxy statement
DXC Technology said its Executive Vice President and Chief Operating Officer, James Brady, will leave the company effective November 29, 2024. His separation payment follows terms previously disclosed in the company's 2024 proxy statement, conditioned on a separation agreement and release.
James Brady, EVP and Chief Operating Officer, exits effective November 29, 2024
Separation payment is tied to a separation agreement and release
Payment terms follow the non-change of control executive officer severance disclosed in the 2024 proxy statement
Macerich said Daniel E. Swanstrom II will become Senior Executive Vice President, Chief Financial Officer and Treasurer effective November 16, 2024, replacing Scott Kingsmore, who will move to Senior Advisor and leave the company on December 31, 2024. The filing describes Swanstrom's real estate finance background and sets out his compensation, including a $600,000 base salary and a $1,500,000 sign-on equity grant.
Daniel E. Swanstrom II, 47, was previously Founder and Managing Member of DES Partners, LLC and CFO of CorePoint Lodging Inc.
Scott W. Kingsmore departs December 31, 2024, and will receive a $100,000 monthly consulting fee for January 1 to March 31, 2025.
Swanstrom's sign-on LTIP grant has a grant date fair value of $1,500,000 and vests ratably over three years; his 2024 bonus is a fixed $375,000 in cash.
CVS Health appointed Prem S. Shah as a newly created Executive Vice President and Group President, responsible for operational performance across CVS Caremark, CVS Pharmacy and Health Care Delivery, including Oak Street Health and Signify Health. It also named Steven H. Nelson as Executive Vice President and President of Aetna, both effective November 6, 2024, with both reporting to CEO David Joyner. The filing describes leadership changes only and includes no financial results or guidance.
Prem S. Shah, age 44, appointed Executive Vice President and Group President, a newly created role, effective November 6, 2024.
Shah previously served as Executive Vice President and Chief Pharmacy Officer and President of Pharmacy & Consumer Wellness since January 2023.
Steven H. Nelson appointed Executive Vice President and President of Aetna; he was most recently CEO of ChenMed and a former CEO of UnitedHealthcare.
The press release is furnished as Exhibit 99.1 under Item 7.01 and is not deemed filed for Section 18 purposes.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.